Anika Therapeutics | ANIK - القيمة السوقية





القيمة السوقية تغيير تاريخ
Abbott USD 158.05B 20.36B 2026-06
Agenus USD 3.19B 3.06B 2026-08
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 10.84B 664M 2026-08
Enanta Pharmaceuticals USD 122M 98M 2024-12
Halozyme Therapeutics USD 10.91B 1.63B 2026-08
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 19.68B 3.43B 2026-08
Integra LifeSciences USD 1.4B 664M 2026-06
J&J USD 611.36B 32.21B 2026-06
Karyopharm Therapeutics USD 221M 95M 2026-08
Ligand Pharmaceuticals USD 5.31B 1.02B 2026-08
MacroGenics USD 184M 82M 2026-03
Merit Medical Systems USD 4.14B 25M 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
Smith & Nephew USD 12.7B 621.83M 2026-06
Stryker USD 120.7B 5.15B 2026-06
Veracyte USD 4.69B 2.12B 2026-06
Xencor USD 1.21B 19M 2026-08
Zimmer Biomet Holdings USD 20.17B 3.51B 2026-08